3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
15
Cholangiocarcinoma
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Carcinoma, Basal Cell
6
Skin Neoplasms
4
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lung Neoplasms
3
Bile Duct Neoplasms
3
Tongue Neoplasms
2
Pleural Diseases
2
Neoplasms
2
Mycosis Fungoides
2
Leukoplakia, Oral
2
Glioblastoma
2
Esophageal Neoplasms
2
Basal Cell Nevus Syndrome
2
Barrett Esophagus
2
Warts
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Skin Diseases
1
Signs and Symptoms
1
Sezary Syndrome
1
Salivary Gland Neoplasms
1
Retinoblastoma
1
Rectal Neoplasms
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Interventions
Cisplatin
17
Radiotherapy
11
Cetuximab
11
Surveys and Questionnaires
10
pembrolizumab
9
Biopsy
9
Radiation
8
Magnetic Resonance Spectroscopy
8
Drug Therapy
8
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
7
Carboplatin
7
X-Rays
6
Specimen Handling
6
Fluorouracil
6
Celecoxib
6
Standard of Care
5
Paclitaxel
5
Observation
5
Sentinel Lymph Node Biopsy
4
Interviews as Topic
4
Chemoradiotherapy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Watchful Waiting
3
Ultrasonography
3
Taxes
3
Practice Guidelines as Topic
3
Positron Emission Tomography Computed Tomography
3
Platinum
3
Optical Imaging
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mouth Neoplasms
×
Photochemotherapy
×
Clear all
NCT03638622
2021-02-21
UH3-India
Massachusetts General Hospital
Phase 1/2
Completed
30 enrolled
4 charts